New hope for kidney stone patients: safer pain relief after surgery?
NCT ID NCT05100017
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two drugs—methocarbamol and oxybutynin—to see which works better for pain and discomfort caused by a ureteral stent placed after kidney stone surgery. About 126 adults aged 18 to 80 who have the surgery will take one of the study drugs along with standard pain medicines. The goal is to find a treatment with fewer side effects that still effectively eases stent-related symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY CALCULI are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Northwestern University
Chicago, Illinois, 60611, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could the type of anesthesia make surgery easier for the surgeon?
- A simple ultrasound test might predict who suffers most from stent pain
- Can a phosphate binder curb kidney stone risk?
- Can a simple tool predict who will be Stone-Free after kidney surgery?
- Can medical glue replace the drainage tube in kidney stone surgery?
- X-ray-free kidney stone surgery put to the test in 500-patient trial